Sunday, September 4, 2016

EpiPen price is NOT a market price

Not one word in this article about the real culprit of high EpiPen prices (and drug prices in general): the FDA, which Mylan lobbies for monopolistic privileges to exclude other competitors. This is crony corporatism, courtesy of Uncle Sam.







No comments:

Post a Comment